Skip to main content
. 2021 Jun 24;13(13):3158. doi: 10.3390/cancers13133158
AFIP Armed Forces Institute of Pathology
CSF1R macrophage colony-stimulating-factor 1 receptor
CTLA4 cytotoxic T-lymphocyte-associated antigen 4
DFS disease-free survival
EGJ esophagogastric junction
EMR endoscopic mucosal resection
ESD endoscopic submucosal dissection
ESEG European Society of Gastrointestinal Endoscopy
ESMO European Society for Medical Oncology
EUS endoscopic ultrasonography
EUS-FNA EUS-guided fine needle aspiration
FDA Food and Drug Administration
FLT3 FMS-like tyrosine kinase 3
GI tract gastrointestinal tract
GIST gastrointestinal stromal tumor
GPR20 G protein-coupled receptor 20
HIF-1α hypoxia-inducible factor-1α
HR hazard ratio
IGF1R insulin growth factor-1 receptor
IHC immunohistochemistry
IMT inflammatory myofibroblastic tumor
LECS laparoscopic endoscopic cooperative surgery
MIAB mucosal incision-assisted biopsy
NCCN National Comprehensive Cancer Network
NIH National Institutes of Health
OS overall survival
PD-1 programmed death-1
PD-L1 programmed death-ligand 1
PEComa perivascular epithelioid cell tumor
PFS progression-free survival
RFS recurrence-free survival
ROSE rapid on-site evaluation
RR response rate
RTK receptor tyrosine kinase
SDH succinate dehydrogenase
SFT solitary fibrous tumor
SMT submucosal tumor
TKI tyrosine kinase inhibitors
Tx therapy
VEGFR vascular endothelial growth factor receptor
SSTR2 somatostatin receptor 2